| 000 | 01607 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517113838.0 | ||
| 264 | 0 | _c20170815 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.826 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdallah, Hisham | |
| 245 | 0 | 0 |
_aPharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _c04 2017 |
||
| 300 |
_a459-468 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aHsu, Joy C | |
| 700 | 1 | _aLu, Peng | |
| 700 | 1 | _aFettner, Scott | |
| 700 | 1 | _aZhang, Xiaoping | |
| 700 | 1 | _aDouglass, Wendy | |
| 700 | 1 | _aBao, Min | |
| 700 | 1 | _aRowell, Lucy | |
| 700 | 1 | _aBurmester, Gerd R | |
| 700 | 1 | _aKivitz, Alan | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 57 _gno. 4 _gp. 459-468 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.826 _zAvailable from publisher's website |
| 999 |
_c26393772 _d26393772 |
||